Member Info for Bermondsey

Nonsense spurting his name. Wtf does dividend have to do with traders - they would be looking for a quick return on capital. I wouldn't second guess what the

catalyst would be for increase in market cap

He sold a chunk at a loss and now insults anyone that hasn't taken the same course of action. Time will tell.

A late buy or a late sell from yesterday just printed. Seems unusually high for this share.

Volume is miniscule not sure I buy your theory. Would like for it to be trued.

Just poking my nose in given the rise. Anything to suggest there is further upside in the short/medium term? All I see is an rns saying the loss isn't going to be as high as anticipated

Product launch territory

Q1 trading update 23 April - will make an interesting read. Shame base rate has held

however, as joey correctly stated - but most of you have blocked him - it was only january when the ceo stated "launch on track for april".

come on tech. it doesn't take the brightest spark to conceive delays in medical sector. joey hasn't been right about anything because he's never put his mind to reaching a reasoned judgement. he's perpetually ****ed off this share hasn't made him a millionaire overnight.

All the best Neil. Sounds like a challenging time for you

Seems like a good appointment. Someone with business acumen. I did chuckle when I read he was already advising on "shareholer communications". The fact that he has waived 85% of remuneration to take performance based is a huge vote of confidence... I reread the rns from yesterday a number of times last night. It really feels like we are gaining momentum now.

Tech I don't agree we've been fed lies. The company is run by medical professionals with interests /jobs outside of company who just want to bring thier product to market. Dissapointing not to better comms but I put this down to them being pretty crap at the business /shareholder side of things. On the other hand I don't see this as a problem. We don't need to butter up new investors for endless cash calls - perhaps this is why they haven't seen the need to improve comms and manage our expectations accordingly. Do I think they're not to be trusted, no I disagree.

Jace on second read of rns I would agree with you. It seems iGenomeDX are clia accredited.

What isn't clear are next steps required to get our product on the market.

We've gone from expected launch in April (further rns saying on track for April launch) to commercial launch layer this year.

@Neilin I'd be interested to hear your take on timescales and where we are in the process.

I think our resident star has a point here.

21 Oct rns: bio aims to achieve clia accreditation before end of 24 with full product launch aimed april 25.

16 December rns: expect to register biomarker as a clia in January 25. Full product launch on track April 25.

Today: igdx 1st to offer biomarker for commercial testing following successful collaboration to meet standards for clia accreditation.

My take on latest rns is they have worked with igdx to prepare a lab/process/test that would meet clia standards but they haven't yet got accreditation.

No longer giving timescales. Near future used again.

Fat finger. Would like to add the income projections are not for the UK company but account for the

us based distributor commission on sales

Would like to add the revenue projections account for our partners share of income from the te

Ok ciz Inc have cleared this up. It's partnered with city of hope - so not us.

Biomarker tech (not bookmarker)

I highlighted before that our US partner/distributor is partnered with a gastric cancer test. A bit more info now added to site. They say launch early 2025 and it uses bookmarked technology. Has anyone come across this / looked into who they are partnered with? Are there others using biomarker technology? Could cizz bio uk be developing this and be ready to launch this product in 25 as well as lung cancer test?

Interestingly they don't specify a launch date / program for the lung cancer test.

Sound advice tech, I have no intention to buy more at this stage. Given the length of time held I also don't intend to divest yet. Would hope for a few spikes even if the worst was to happen.